Meet 52 richest Indians in Pharma Healthcare domain Farhat Nasim21 Sept 2022 7:33 PM ISTNew Delhi: The pharmaceutical sector minted the most number of dollar billionaires with 36 entrepreneurs in the recently released IIFL Wealth Hurun...
Intas Pharma bags CDSCO panel nod to study Human Normal Immunoglobulin Rahul Verma26 July 2022 5:30 PM ISTPharmaceutical major Intas Pharma has got the go-head from the Subject Expert Committee (SEC) functional under Central Drug Standard Control...
Intas Pharma Gets CDSCO Panel Okay To Study Human Normal Immunoglobulin Dr. Divya Colin25 July 2022 6:00 PM ISTNew Delhi: Pharmaceutical major Intas Pharma has got the go-head from the Subject Expert Committee (SEC) functional under Central Drug Standard...
Delhi HC relief to Intas- stops two pharma companies from violating trademark of LOOZ Roshni Dhar27 Jun 2022 7:00 PM ISTThe Delhi High Court has permanently restrained two pharmaceutical manufacturers from using the trademark 'LOOZOUT' in their products, which is...
Health Bulletin 27/June/2022 Roshni Dhar27 Jun 2022 4:25 PM ISTHere are the top health stories for the day :Medical Council suspends doctor for negligence in knee replacement surgery ...
Delhi HC relief to Intas- Stops two pharma companies from violating trademark of LOOZ Ruchika Sharma25 Jun 2022 2:30 PM ISTNew Delhi: The Delhi High Court has permanently restrained two pharmaceutical manufacturers from using the trademark 'LOOZOUT' in their products,...
CDSCO Panel approves Intas Ranibizumab for new indication: retinopathy of pre maturity in preterm infants Dr. Divya Colin12 Jun 2022 1:18 PM ISTNew Delhi: Considering the fact that the target subjects are infants, the Subject Expert Committee (SEC) functional under Central Drug Standard...
Include more sites from govt hospitals: CDSCO panel tells Intas on Tofacitinib Ointment 2% CT study Dr. Divya Colin15 May 2022 12:30 PM ISTNew Delhi: Directing the pharma major Intas Pharma to include more study sites from government hospitals geographically distributed in the country,...
Intas Pharma, Comera Life Sciences ink pact for bio-innovative biologic medicines Ruchika Sharma20 April 2022 11:19 AM ISTAhmedabad: Comera Life Sciences, Inc. and Intas Pharmaceuticals Ltd. have announced a research collaboration to develop a new...
NPPA fixes retail prices of 15 formulations, ceiling price of Framycetin Ruchika Sharma19 April 2022 4:06 PM ISTNew Delhi: National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India has fixed retail prices of 15...
Intas Pharma, Axantia collaborate for Ranibizumab in Middle East Ruchika Sharma5 April 2022 12:20 PM ISTIntas has developed a biosimilar of Lucentis, which is currently under Phase III global trial for submission in major countries including EMA and the...
NPPA panel fixes retail price of Intas Pharma Normal Human Immunoglobulin 5% solution Dr. Divya Colin6 March 2022 12:30 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority(NPPA) panel has fixed the retail price of each vial of Normal Human Immunoglobulin 5%...
